OBJECTIVE: To investigate whether the widely varying estimates of the prevalence of anti-Ku autoantibodies are explained by racial/ethnic differences. METHODS: Consecutive African American or white patients who met the 1982 criteria for systemic lupus erythematosus (SLE) and who were evaluated over 10 years in North Carolina, Florida, and New York were tested by immunoprecipitation of K562 cell extract for anti-Ku as well as anti-nuclear RNP (nRNP)/Sm, anti-Ro/SSA, and anti-La/SSB autoantibodies. RESULTS: Anti-Ku autoantibodies were detected in sera from 18 of 155 African American patients with SLE (12%) versus 0 of 126 white patients (P < 0.0001, by Fisher's exact test). Anti-nRNP (63% versus 16%; P < 0.0001) and anti-Sm (23% versus 7%; P < 0.0004) autoantibodies were also more common in the African American subset. The 2 groups had comparable frequencies of anti-Ro/SSA and anti-La/SSB autoantibodies. CONCLUSION: Anti-Ku antibodies are common in African American patients with SLE but rare in whites, probably explaining the different estimates of their prevalence. In African Americans, the frequency is comparable with that of anti-La/SSB. Along with anti-Ku, anti-nRNP and anti-Sm autoantibodies are also overrepresented in African Americans, suggesting that a group of specificities is characteristically associated with SLE in African Americans.
OBJECTIVE: To investigate whether the widely varying estimates of the prevalence of anti-Ku autoantibodies are explained by racial/ethnic differences. METHODS: Consecutive African American or white patients who met the 1982 criteria for systemic lupus erythematosus (SLE) and who were evaluated over 10 years in North Carolina, Florida, and New York were tested by immunoprecipitation of K562 cell extract for anti-Ku as well as anti-nuclear RNP (nRNP)/Sm, anti-Ro/SSA, and anti-La/SSB autoantibodies. RESULTS: Anti-Ku autoantibodies were detected in sera from 18 of 155 African American patients with SLE (12%) versus 0 of 126 white patients (P < 0.0001, by Fisher's exact test). Anti-nRNP (63% versus 16%; P < 0.0001) and anti-Sm (23% versus 7%; P < 0.0004) autoantibodies were also more common in the African American subset. The 2 groups had comparable frequencies of anti-Ro/SSA and anti-La/SSB autoantibodies. CONCLUSION: Anti-Ku antibodies are common in African American patients with SLE but rare in whites, probably explaining the different estimates of their prevalence. In African Americans, the frequency is comparable with that of anti-La/SSB. Along with anti-Ku, anti-nRNP and anti-Sm autoantibodies are also overrepresented in African Americans, suggesting that a group of specificities is characteristically associated with SLE in African Americans.
Authors: Minoru Satoh; Edward K L Chan; Lindsey A Ho; Kathryn M Rose; Christine G Parks; Richard D Cohn; Todd A Jusko; Nigel J Walker; Dori R Germolec; Irene Z Whitt; Patrick W Crockett; Brad A Pauley; Jason Y F Chan; Steven J Ross; Linda S Birnbaum; Darryl C Zeldin; Frederick W Miller Journal: Arthritis Rheum Date: 2012-07
Authors: S Hoa; M Hudson; Y Troyanov; S Proudman; J Walker; W Stevens; M Nikpour; S Assassi; M D Mayes; M Wang; M Baron; M J Fritzler Journal: Medicine (Baltimore) Date: 2016-08 Impact factor: 1.889
Authors: Katalin Szabó; Levente Bodoki; Melinda Nagy-Vincze; Anett Vincze; Erika Zilahi; Peter Szodoray; Katalin Dankó; Zoltán Griger Journal: Biomed Res Int Date: 2018-10-25 Impact factor: 3.411
Authors: Monica Vázquez-Del Mercado; Claudia A Palafox-Sánchez; Jose F Muñoz-Valle; Gerardo Orozco-Barocio; Edith Oregon-Romero; Rosa E Navarro-Hernández; Mario Salazar-Páramo; Juan Armendariz-Borunda; Jorge I Gámez-Nava; Laura Gonzalez-Lopez; Jason Yf Chan; Edward Kl Chan; Minoru Satoh Journal: Arthritis Res Ther Date: 2010-01-08 Impact factor: 5.156
Authors: Maria Casal-Dominguez; Iago Pinal-Fernandez; Assia Derfoul; Rose Graf; Harlan Michelle; Jemima Albayda; Eleni Tiniakou; Brittany Adler; Sonye K Danoff; Thomas E Lloyd; Lisa Christoper-Stine; Julie J Paik; Andrew L Mammen Journal: Semin Arthritis Rheum Date: 2021-04-28 Impact factor: 5.431